These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 32649639)
21. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695 [TBL] [Abstract][Full Text] [Related]
22. Hypertension Management in Older and Frail Older Patients. Benetos A; Petrovic M; Strandberg T Circ Res; 2019 Mar; 124(7):1045-1060. PubMed ID: 30920928 [TBL] [Abstract][Full Text] [Related]
23. Current issues in frailty and hypertension management. Yamamoto K Hypertens Res; 2023 Aug; 46(8):1917-1922. PubMed ID: 37280259 [TBL] [Abstract][Full Text] [Related]
24. Diastolic hypotension due to intensive blood pressure therapy: Is it harmful? Stensrud MJ; Strohmaier S Atherosclerosis; 2017 Oct; 265():29-34. PubMed ID: 28841431 [TBL] [Abstract][Full Text] [Related]
25. Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients. Scott IA; Hilmer SN; Le Couteur DG Drugs Aging; 2019 Aug; 36(8):675-685. PubMed ID: 31175614 [TBL] [Abstract][Full Text] [Related]
26. Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials. Atkins ER; Hirakawa Y; Salam A; Woodward M; Cooper M; Hamet P; Harrap S; Lees K; Liu L; Mancia G; Marre M; Perkovic V; Poulter N; Williams B; Chalmers J; Rodgers A J Hypertens; 2017 Jun; 35(6):1318-1325. PubMed ID: 28169881 [TBL] [Abstract][Full Text] [Related]
27. Older people remain on blood pressure agents despite being hypotensive resulting in increased mortality and hospital admission. Morrissey Y; Bedford M; Irving J; Farmer CK Age Ageing; 2016 Nov; 45(6):783-788. PubMed ID: 27496937 [TBL] [Abstract][Full Text] [Related]
28. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure: overview and meta-analyses of randomized trials. Thomopoulos C; Parati G; Zanchetti A J Hypertens; 2017 Nov; 35(11):2138-2149. PubMed ID: 28858983 [TBL] [Abstract][Full Text] [Related]
29. Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure. Park S Korean J Intern Med; 2019 Jan; 34(1):44-49. PubMed ID: 30612417 [TBL] [Abstract][Full Text] [Related]
30. [SPRINT study: far lower systolic blood pressure]. Souček M; Řiháček I; Novák J Cas Lek Cesk; 2016; 155(4):9-12. PubMed ID: 27481195 [TBL] [Abstract][Full Text] [Related]
31. Risks associated with intensive blood pressure control in older patients. Rivasi G; Ceolin L; Capacci M; Matteucci G; Testa GD; Ungar A Kardiol Pol; 2023; 81(5):446-454. PubMed ID: 36999732 [TBL] [Abstract][Full Text] [Related]
32. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey). Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605 [TBL] [Abstract][Full Text] [Related]
33. Impact of lower achieved blood pressure on outcomes in hypertensive patients. Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB J Hypertens; 2012 Apr; 30(4):802-10; discussion 810. PubMed ID: 22343536 [TBL] [Abstract][Full Text] [Related]
34. [Limits to the treatment of hypertension]. Kalkman DN; Brouwer TF; Spiering W; Peters RJG; van den Born BJH Ned Tijdschr Geneeskd; 2018 Oct; 162():. PubMed ID: 30379497 [TBL] [Abstract][Full Text] [Related]
35. Potential of Stratified Medicine for High Blood Pressure Management: A Modeling Study Using NHANES Survey Data. Porcher R; Tran VT; Blacher J; Ravaud P Hypertension; 2019 Dec; 74(6):1420-1427. PubMed ID: 31679427 [TBL] [Abstract][Full Text] [Related]
36. Blood pressure management in older people: balancing the risks. Naschitz JE Postgrad Med J; 2018 Jun; 94(1112):348-353. PubMed ID: 29555655 [TBL] [Abstract][Full Text] [Related]
37. Management of Hypertension in the Elderly and Frail Elderly. Ferri C; Ferri L; Desideri G High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):1-11. PubMed ID: 28181201 [TBL] [Abstract][Full Text] [Related]
38. Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: rationale, design, and methods. Fukui T; Rahman M; Hayashi K; Takeda K; Higaki J; Sato T; Fukushima M; Sakamoto J; Morita S; Ogihara T; Fukiyama K; Fujishima M; Saruta T; Hypertens Res; 2003 Dec; 26(12):979-90. PubMed ID: 14717341 [TBL] [Abstract][Full Text] [Related]
39. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. Liu L; Zhang Y; Liu G; Li W; Zhang X; Zanchetti A; J Hypertens; 2005 Dec; 23(12):2157-72. PubMed ID: 16269957 [TBL] [Abstract][Full Text] [Related]
40. Target Blood Pressure in Patients with Diabetes: Asian Perspective. Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH; Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]